Head & Neck Cancers | Specialty

The OncLive Head and Neck Cancer condition center page is a comprehensive resource for clinical news and expert insights on treatment for patients with head and neck cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research within head and neck cancer.

Cabozantinib Active as Salvage Therapy in Thyroid Cancer

September 5th 2017

Cabozantinib (Cabometyx) demonstrated durable activity in patients with radioiodine-refractory differentiated thyroid cancer who progressed on VEGFR-targeted therapy.

Pembrolizumab Active in Advanced Nasopharyngeal Carcinoma

August 29th 2017

Pembrolizumab (Keytruda) induced an overall response rate of 25.9% and was well tolerated in patients with PD-L1–positive recurrent or metastatic nasopharyngeal carcinoma.

Dr. Siegel on Induction Therapy for Head and Neck Cancer

August 28th 2017

Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses induction therapy for head and neck cancer.

Dr. Siegel on Benefits With Transoral Surgery and Chemotherapy for Head and Neck Cancer

August 24th 2017

Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses the benefits of chemotherapy and transoral surgery for patients with head and neck cancer.

Dr. Siegel on Study of Induction Chemotherapy and Transoral Surgery in Oropharyngeal Cancer

August 23rd 2017

Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses a study of induction chemotherapy and transoral surgery in patients with oropharyngeal cancer.

Dr. Siegel on the Da Vinci Robotic Assisted Surgery Technique in Head and Neck Cancer

August 18th 2017

Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses the da Vinci robotic-assisted surgery technique in head and neck cancer.

Dr. Bauml on the Unmet Need in Head and Neck Cancer

August 18th 2017

Joshua Bauml, MD, assistant professor, Perelman School of Medicine, University of Pennsylvania, discusses an unmet need for patients with head and neck cancer.

EBV DNA Screening Detects Early Asymptomatic Nasopharyngeal Carcinoma

August 15th 2017

Hong Kong researchers were able to detect nasopharyngeal carcinoma significantly earlier by screening for circulating cell-free Epstein-Barr virus DNA.

Dr. Weiss Discusses Prevention in Head and Neck Cancer

August 14th 2017

Jared Weiss, MD, assistant professor, UNC Lineberger Comprehensive Cancer Center, discusses prevention in head and neck cancer.

Novel Regimen May Eliminate Need for Radiation in Some Oropharyngeal Cancers

August 11th 2017

Robert Siegel, MD, discusses the 13-month follow-up of the combination of induction chemotherapy and transoral surgery in oropharyngeal squamous cell carcinoma.

Frontline Pembrolizumab Explored in Head and Neck Cancer

August 11th 2017

Jean-Pascal Machiels, MD, discusses the KEYNOTE-412 trial and the overall potential for pembrolizumab in the head and neck cancer landscape.

Key Points for Treatment of Advanced HNSCC

August 10th 2017

Next Steps in Research for Immunotherapy for HNSCC

August 10th 2017

Immunotherapy in the Peri-Operative Setting of HNSCC

August 10th 2017

Immunotherapy Combinations for HNSCC

August 10th 2017

Emerging Checkpoint Inhibitors for HNSCC

August 10th 2017

Take-Home Messages: Immunotherapy for HNSCC

August 10th 2017

Practical Issues Surrounding Immunotherapy for HNSCC

August 10th 2017

Pseudoprogression on Immunotherapy in HNSCC

August 10th 2017

Immunotherapy for HNSCC

August 10th 2017